✦ LIBER ✦

A phase II study of interferon alfa-2b treatment of anti-HCV positive and negative chronic NANB hepatitis: Interim analysis

✍ Scribed by Varagona, G; Kibbler, H; Smith, M; Sherlock, S; Dusheiko, G

Book ID: 123537602
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 115 KB
Volume: 11
Category: Article
ISSN: 0168-8278
DOI: 10.1016/0168-8278(90)90195-W

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An interim analysis of the response to t

An interim analysis of the response to treatment of chronic hepatitis C with interferon-alfa-2b and ribavirin in a VA population

✍ Edelstein, Marc A.; Ly, David; Saab, Sammy; Weston, Shiobhan; Lunn, Adrian; Garr 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Interferon α-2b with and without ribavir

Interferon α-2b with and without ribavirin in the treatment of hepatitis B e antigen–positive chronic hepatitis B: A randomized study

✍ Chun-Jen Liu; Ming-Yang Lai; You-Chen Chao; Li-Ying Liao; Sien-Sing Yang; Tun-Je 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 1 views

To study whether interferon (IFN) ␣ and ribavirin combination therapy has a beneficial effect for hepatitis B e antigen (HBeAg)-positive chronic hepatitis B, we enrolled 119 such patients in a randomized study. Fifty-nine patients received 5 million units of IFN-␣2b daily for 4 weeks followed by 5 m

Treatment of Chronic Hepatitis due to He

Treatment of Chronic Hepatitis due to Hepatitis C Virus (CH-C) in India: A Randomized Controlled Trial Comparing Daily Interferon-alfa-2b and Ribavirin with Daily Interferon-alfa-2b and Glycyrrhizin—A Multicenter Study

✍ Subrat K Acharya; V Sreenivas; Siddharth Datta Gupta; Shakti Kumar; Yogesh K Cha 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 186 KB

Combination therapy of E-antigen-negativ

Combination therapy of E-antigen-negative/virus-DNA-positive (precore mutant) chronic hepatitis B with famciclovir or lamivudine and interferon (IFN) alfa-2a

✍ I. Schiefke; U. Oesen; G. Etzrodt; M. Wiedmann; U.G. Liebert; J. Moessner; F. Be 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Efficacy and Safety of Pegylated Interfe

Efficacy and Safety of Pegylated Interferon Alfa-2a or Alfa-2b Plus Ribavirin for the Treatment of Chronic Hepatitis C in Children and Adolescents: A Systematic Review and Meta-analysis

✍ Druyts, E.; Thorlund, K.; Wu, P.; Kanters, S.; Yaya, S.; Cooper, C. L.; Mills, E 📂 Article 📅 2012 🏛 University of Chicago Press 🌐 English ⚖ 107 KB

A phase II study of the combination of h

A phase II study of the combination of histamine dihydrochloride and interferon alpha-2b (IFN-α-2b) as initial therapy in chronic hepatitis C (HCV) patients: 48-week results

✍ Lurie, Yoav; Hyle, Sandy; Gehlsen, Kurt R. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 357 KB